Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer-Reference-Cited by-同舟云学术

Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer

Published:2022-01-20 Issue:1 Volume:8 Page:e215445
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Fokas Emmanouil¹²³,Schlenska-Lange Anke⁴,Polat Bülent⁵,Klautke Gunther⁶,Grabenbauer Gerhard G.⁷,Fietkau Rainer⁸,Kuhnt Thomas⁹,Staib Ludger¹⁰,Brunner Thomas¹¹,Grosu Anca-Ligia¹²¹³,Kirste Simon¹²¹³,Jacobasch Lutz¹⁴,Allgäuer Michael¹⁵,Flentje Michael⁵,Germer Christoph-Thomas¹⁶,Grützmann Robert¹⁷,Hildebrandt Guido¹⁸,Schwarzbach Matthias¹⁹,Bechstein Wolf O.²⁰,Sülberg Heiko²¹,Friede Tim²²,Gaedcke Jochen²³,Ghadimi Michael²³,Hofheinz Ralf-Dieter²⁴,Rödel Claus¹²³,Imhoff Detlef²⁵,Woeste Guido²⁵,Habbe Nils²⁵,Pession Ursula²⁵,Hansmann Martin-Leo²⁵,Wild Peter²⁵,Falk Stephan²⁵,Hödl Petra²⁵,Serebrennikov Andre²⁵,Schmeck Sanja²⁵,Paolucci Vittorio²⁵,Sahm Stephan²⁵,Eichel Martin²⁵,Römer Giovanna²⁵,Bank Wolfgang²⁵,Moosmann Nicolas²⁵,Braess Jan²⁵,Piso Popiliu²⁵,Wiesinger Heinrich²⁵,Kappl Peter²⁵,Germer Elisabeth²⁵,Warmuth-Metz Monika²⁵,Kunzmann Volker²⁵,Krajinovic Katica²⁵,Rosenwald Andreas²⁵,Bley Thorsten²⁵,Stölzel Ulrich²⁵,Dörne Manfred²⁵,Renziehausen Lutz²⁵,Boese-Land Joachim²⁵,Meißner Dietrich²⁵,Burchert Dagmar²⁵,Dirsch Olaf²⁵,Habeck Jörg Olaf²⁵,Kirchhof Klaus²⁵,Lamberti Christof²⁵,Leibl Bernhard²⁵,Gschwendtner Andreas²⁵,Lahmer Godehard²⁵,Lang-Welzenbach Marga²⁵,Hohenberger Werner²⁵,Kuhnt Thomas²⁵,Papsdorf Kirsten²⁵,Wittekind Christian²⁵,Volkheimer Christine²⁵,Wenz Frederik²⁵,Merx Kirsten²⁵,Post Stefan²⁵,Gaiser Timo²⁵,Attenberger Ulrike²⁵,Geißler Michael²⁵,Sträter Jörn²⁵,Gnann Helmut²⁵,Krämer Stefan²⁵,Henke Michael²⁵,Schäfer Henning²⁵,Manegold Philipp²⁵,Neeff Hannes Philipp²⁵,Bronsert Peter²⁵,Schmiegel Wolff²⁵,Pohl Michael²⁵,Möllecken Christian²⁵,Adamietz Irenäus²⁵,Viehbahn Richard²⁵,Tannapfel Andrea²⁵,Freiberg-Richter Jens²⁵,Jacobi Thorsten²⁵,Wendt Wolfgang²⁵,Holzweißig Klaus²⁵,Kittner Thomas²⁵,Graeven Ullrich²⁵,Lange Christiane²⁵,Kania Ulrich²⁵,Rösler Elisabeth²⁵,Ortloff Harold²⁵,Müller-Leisse Christoph²⁵,Folprecht Gunnar²⁵,Ubbelohde Ulrike²⁵,Baretton Gustavo²⁵,Kölbl Oliver²⁵,Steger Felix²⁵,Hofstädter Ferdinand²⁵,Schlitt Hans Jürgen²⁵,Stroszczynski Christian²⁵,Binnebösel Marcel²⁵,Eble Michael J.²⁵,Lüdde Tom²⁵,Knüchel-Clarke Ruth²⁵,Bruners Philipp²⁵,Küchenmeister Ute²⁵,Klar Ernst²⁵,Erbesdolber Andreas²⁵,Halm Ulrich²⁵,Zachäus Markus²⁵,Schneider Eckhardt²⁵,Schmidt Thomas²⁵,Köhne Claus-Henning²⁵,Rosin Bernd²⁵,Willborn Kay C.²⁵,Henke Rolf-Peter²⁵,Griesinger Frank²⁵,Flach Hagen²⁵,

Affiliation:

1. Department of Radiotherapy and Oncology, University of Frankfurt, Frankfurt, Germany

2. German Cancer Research Center, German Cancer Consortium, Frankfurt, Germany

3. Frankfurt Cancer Institute, Frankfurt, Germany

4. Department of Haematology and Oncology, Barmherzige Brüder Hospital, Regensburg, Germany

5. Department of Radiation Oncology, University of Würzburg, Würzburg, Germany

6. Department of Radiation Therapy, Poliklinik Chemnitz GmbH, Chemnitz, Germany

7. Department of Radiation Oncology and Radiotherapy, DiaCura & Klinikum Coburg, Coburg, Germany

8. Department of Radiation Therapy, University of Erlangen-Nürnberg, Erlangen, Germany

9. Department of Radiation Therapy, University of Leipzig, Leipzig, Germany

10. Department of General and Visceral Surgery, Klinikum Esslingen, Germany

11. Department of Radiation Therapy, University of Magdeburg, Magdeburg, Germany

12. Department of Radiation Oncology, Medical Center University of Freiburg, Faculty of Medicine, Freiburg, Germany

13. German Cancer Research Center, German Cancer Consortium, Freiburg, Germany

14. Praxis of Haematology and Oncology, Dresden, Germany

15. Department of Radiotherapy, Barmherzige Brüder Hospital Regensburg, Regensburg, Germany

16. Department of General and Visceral Surgery, University of Würzburg, Würzburg, Germany

17. Department of General and Visceral Surgery, University of Erlangen-Nürnberg, Erlangen, Germany

18. Department of Radiotherapy and Oncology, University of Rostock, Rostock, Germany

19. Department of General and Visceral Surgery, Klinikum Frankfurt Höchst, Germany

20. Department of General and Visceral Surgery, University of Frankfurt, Frankfurt, Germany

21. X-act Cologne Clinical Research GmbH, Cologne, Germany

22. Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany

23. Department of General and Visceral Surgery, University Medical Center Göttingen, Göttingen, Germany

24. Department of Medical Oncology, University Hospital Mannheim, Mannheim, Germany

25. for the German Rectal Cancer Study Group

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2786405/jamaoncology_fokas_2021_oi_210080_1642642447.35951.pdf

Reference25 articles.

1. Total neoadjuvant therapy vs standard therapy in locally advanced rectal cancer: a systematic review and meta-analysis.;Kasi;JAMA Netw Open,2020

2. Total neoadjuvant therapy in rectal cancer: a systematic review and meta-analysis of treatment outcomes.;Petrelli;Ann Surg,2020

3. Adoption of total neoadjuvant therapy for locally advanced rectal cancer.;Cercek;JAMA Oncol,2018

4. Outcome measures in multimodal rectal cancer trials.;Fokas;Lancet Oncol,2020

5. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.;Conroy;Lancet Oncol,2021

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgical and local control outcomes after sequential short-course radiation therapy and chemotherapy for rectal cancer;Surgery Open Science;2024-03

2. Effect of adjuvant chemotherapy on the oncological outcome of rectal cancer patients with pathological complete response;World Journal of Surgical Oncology;2024-01-25

3. Anus preservation in low rectal adenocarcinoma based on MMR/MSI status (APRAM): a study protocol for a randomised, controlled, open-label, multicentre phase III trial;BMC Cancer;2024-01-10

4. Adoption of Total Neoadjuvant Therapy in the Treatment of Locally Advanced Rectal Cancer;Current Oncology;2024-01-10

5. Retrospective cohort study for thrombocytopenia during concurrent chemoradiotherapy for rectal cancer;Frontiers in Oncology;2024-01-02